Heparin is a promising agent for the treatment of endometriosis-associated fibrosis

Nasu K, Kaei Nasu, Akitoshi Tsuno, Tsuno A, Marina Hirao, Hirao M, Kobayashi H, Hironao Kobayashi, Akitoshi Yuge, Yuge A, Narahara H, Hisashi Narahara
Fertility and sterility · 2009 · vol. 94(1) , pp. 46–51 · doi:10.1016/j.fertnstert.2009.02.057 · PMID:19338998 · W2133473958
article OA: bronze CC0 ⤵ 13 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated heparin as a potential treatment for endometriosis-associated fibrosis, finding it to be a promising agent.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo assess the use of heparin for the medical treatment of endometriosis-associated fibrosis.DesignThe effects of heparin on the endometriotic stromal cells (ECSCs)-mediated contractility were investigated.SettingResearch laboratory at a medical school.Patient(s)Endometriotic tissues from nine patients were used.Intervention(s)Endometriotic stromal cells were cultured three dimensionally in the presence of heparin.Main outcome measure(s)The contractility of ECSCs was assessed by collagen gel contraction assay. Heparin-induced morphological changes of ECSCs were evaluated by laser scanning microscopy. The expression of contractility-related molecules in ECSCs was examined by Western blot analysis.Result(s)In the presence of 10% fetal bovine serum, treated ECSCs showed significant collagen gel contractility (75.9% decrease in surface area after 48 hour vs. 0 hour controls). Endometriotic stromal cell-mediated gel contraction was significantly attenuated in the presence of heparin in a dose-dependent manner (55.7% reduction of the gel contraction at a concentration of 100 microg/mL of heparin sodium versus untreated controls after 48 hours). Heparin suppressed the ECSC attachment to collagen fibers. The expression of alpha-smooth muscle actin, Ras homology (Rho) A, Rho-associated coiled-coil-forming protein kinase (ROCK)-I, and ROCK-II was down-regulated by heparin administration.Conclusion(s)The present study suggests that heparin is a promising agent for the treatment of endometriosis-associated fibrosis. The inhibition of myofibroblastic differentiation, the attenuation of attachment to collagen fibers, and the suppression of Rho-ROCK-mediated pathway activation in ECSCs are involved in the action mechanisms of heparin.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Heparin Adult Animals Cattle Cells, Cultured Collagen Collagen Endometriosis Endometrium Endometrium Endometrium Female Fibrosis Heparin Heparin Humans Stromal Cells Stromal Cells

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (14)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:11.755070+00:00
License: CC0 · commercial use OK